-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on Chemours, Raises Price Target to $21

Benzinga·03/05/2026 13:43:23
Listen to the news
Mizuho analyst John Roberts maintains Chemours (NYSE:CC) with a Outperform and raises the price target from $17 to $21.